CID 104246

12227-47-3

Structural Information

Molecular Formula
C30H16N4O5
SMILES
C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)C4=NN=C(O4)C5=C(C6=C(C=C5)C(=O)C7=CC=CC=C7C6=O)N)N
InChI
InChI=1S/C30H16N4O5/c31-23-19(11-9-17-21(23)27(37)15-7-3-1-5-13(15)25(17)35)29-33-34-30(39-29)20-12-10-18-22(24(20)32)28(38)16-8-4-2-6-14(16)26(18)36/h1-12H,31-32H2
InChIKey
HFLBGLHPZPFPAU-UHFFFAOYSA-N
Compound name
1-amino-2-[5-(1-amino-9,10-dioxoanthracen-2-yl)-1,3,4-oxadiazol-2-yl]anthracene-9,10-dione
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

42
Patents

512.11206 Da
Monoisotopic Mass

4.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 513.11934 224.9
[M+Na]+ 535.10128 235.5
[M-H]- 511.10478 236.4
[M+NH4]+ 530.14588 231.0
[M+K]+ 551.07522 229.1
[M+H-H2O]+ 495.10932 212.2
[M+HCOO]- 557.11026 238.6
[M+CH3COO]- 571.12591 232.3
[M+Na-2H]- 533.08673 225.3
[M]+ 512.11151 226.2
[M]- 512.11261 226.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe